Selected research
Industry Growth & Trends
Global CAR-T Cellular Immunotherapy Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global CAR-T Cellular Immunotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CAR-T Cellular Immunotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the CAR-T Cellular Immunotherapy market include Novartis, Gilead Sciences, Fosun Kite Biotechnology and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global CAR-T Cellular Immunotherapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The CAR-T Cellular Immunotherapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global CAR-T Cellular Immunotherapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to CAR-T Cellular Immunotherapy.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global CAR-T Cellular Immunotherapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
CAR-T Cellular Immunotherapy Market by Company
Novartis
Gilead Sciences
Fosun Kite Biotechnology
Bristol-Myers Squibb
CAR-T Cellular Immunotherapy Segment by Type
Allogeneic
Autologous
CAR-T Cellular Immunotherapy Segment by Application
Hospital
Pharmacy
Other
CAR-T Cellular Immunotherapy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CAR-T Cellular Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CAR-T Cellular Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CAR-T Cellular Immunotherapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of CAR-T Cellular Immunotherapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Allogeneic
- Autologous
Applications
- Hospital
- Pharmacy
- Other
Companies covered
- Novartis
- Gilead Sciences
- Fosun Kite Biotechnology
- Bristol-Myers Squibb
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global CAR-T Cellular Immunotherapy Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global CAR-T Cellular Immunotherapy Market Size by Region (2021-2032)
- 1.4.1 Global CAR-T Cellular Immunotherapy Market Size by Region (2021-2026)
- 1.4.2 Global CAR-T Cellular Immunotherapy Market Size by Region (2027-2032)
- 1.5 Key Regions CAR-T Cellular Immunotherapy Market Size (2021-2032)
- 1.5.1 North America CAR-T Cellular Immunotherapy Market Size Growth Rate (2021-2032)
- 1.5.2 Europe CAR-T Cellular Immunotherapy Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size Growth Rate (2021-2032)
- 1.5.4 South America CAR-T Cellular Immunotherapy Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa CAR-T Cellular Immunotherapy Market Size Growth Rate (2021-2032)
2 CAR-T Cellular Immunotherapy Market by Type
- 2.1 Type Introduction
- 2.1.1 Allogeneic
- 2.1.2 Autologous
- 2.2 Global CAR-T Cellular Immunotherapy Market Size by Type
- 2.2.1 Global CAR-T Cellular Immunotherapy Market Size Overview by Type (2021-2032)
- 2.2.2 Global CAR-T Cellular Immunotherapy Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global CAR-T Cellular Immunotherapy Market Size Forecasted by Type (2027-2032)
- 2.3 Global CAR-T Cellular Immunotherapy Market Size by Regions
- 2.3.1 North America CAR-T Cellular Immunotherapy Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe CAR-T Cellular Immunotherapy Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America CAR-T Cellular Immunotherapy Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa CAR-T Cellular Immunotherapy Market Size Breakdown by Type (2021-2026)
3 CAR-T Cellular Immunotherapy Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Pharmacy
- 3.1.3 Other
- 3.2 Global CAR-T Cellular Immunotherapy Market Size by Application
- 3.2.1 Global CAR-T Cellular Immunotherapy Market Size Overview by Application (2021-2032)
- 3.2.2 Global CAR-T Cellular Immunotherapy Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global CAR-T Cellular Immunotherapy Market Size Forecasted by Application (2027-2032)
- 3.3 Global CAR-T Cellular Immunotherapy Market Size by Regions
- 3.3.1 North America CAR-T Cellular Immunotherapy Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe CAR-T Cellular Immunotherapy Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America CAR-T Cellular Immunotherapy Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa CAR-T Cellular Immunotherapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 CAR-T Cellular Immunotherapy Industry Trends
- 4.2 CAR-T Cellular Immunotherapy Industry Drivers
- 4.3 CAR-T Cellular Immunotherapy Industry Opportunities and Challenges
- 4.4 CAR-T Cellular Immunotherapy Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by CAR-T Cellular Immunotherapy Revenue (2021-2026)
- 5.2 Global CAR-T Cellular Immunotherapy Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global CAR-T Cellular Immunotherapy Key Company Headquarters & Area Served
- 5.4 Global CAR-T Cellular Immunotherapy Company, Product Type & Application
- 5.5 Global CAR-T Cellular Immunotherapy Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global CAR-T Cellular Immunotherapy Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 CAR-T Cellular Immunotherapy Players Market Share by Revenue in 2025
- 5.6.3 2025 CAR-T Cellular Immunotherapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis CAR-T Cellular Immunotherapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis CAR-T Cellular Immunotherapy Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Gilead Sciences
- 6.2.1 Gilead Sciences Company Information
- 6.2.2 Gilead Sciences Business Overview
- 6.2.3 Gilead Sciences CAR-T Cellular Immunotherapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Gilead Sciences CAR-T Cellular Immunotherapy Product Portfolio
- 6.2.5 Gilead Sciences Recent Developments
- 6.3 Fosun Kite Biotechnology
- 6.3.1 Fosun Kite Biotechnology Company Information
- 6.3.2 Fosun Kite Biotechnology Business Overview
- 6.3.3 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Fosun Kite Biotechnology CAR-T Cellular Immunotherapy Product Portfolio
- 6.3.5 Fosun Kite Biotechnology Recent Developments
- 6.4 Bristol-Myers Squibb
- 6.4.1 Bristol-Myers Squibb Company Information
- 6.4.2 Bristol-Myers Squibb Business Overview
- 6.4.3 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Bristol-Myers Squibb CAR-T Cellular Immunotherapy Product Portfolio
- 6.4.5 Bristol-Myers Squibb Recent Developments
7 North America
- 7.1 North America CAR-T Cellular Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 7.3 North America CAR-T Cellular Immunotherapy Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe CAR-T Cellular Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 8.3 Europe CAR-T Cellular Immunotherapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific CAR-T Cellular Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 9.3 Asia-Pacific CAR-T Cellular Immunotherapy Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America CAR-T Cellular Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 10.3 South America CAR-T Cellular Immunotherapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa CAR-T Cellular Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa CAR-T Cellular Immunotherapy Market Size by Country (2021-2026)
- 11.3 Middle East & Africa CAR-T Cellular Immunotherapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst